Other News

Picard Medical and its Subsidiary, SynCardia Systems, a Pioneer in Total Artificial Heart Technology, to Become a Publicly Traded Company via Merger with Altitude Acquisition Corp.

SynCardia Manufactures and Distributes the First-and-Only Commercially Available and FDA Approved Total Artificial Heart SynCardia is Entering a Rapid Growth Phase Supported by New Product Development, Label Expansion, and International Growth Transaction Estimates a Pre-Money Enterprise Value of $480 Million for Picard Medical Picard Medical Stockholders Will Roll 100% of Their Existing […]

HDL Therapeutics Inc Plans to Become Publicly Traded via a Business Combination With $225 Million Swiftmerge (NASDAQ: IVCP) With Goal to Transform Cardiovascular Disease Treatment

NEW YORK & VERO BEACH, Fla.–(BUSINESS WIRE)–NASDAQ IVCP Swiftmerge Acquisition Corp (“Swiftmerge”), a $225 million innovative healthcare investment corporation and a special purpose acquisition company, announced today the signing of a non-binding letter of intent (“LOI”) for a business combination with HDL Therapeutics Inc. (“HDL Therapeutics”), a privately held commercial […]

First Coast Cardiovascular Institute Announces Partnership With Cardiovascular Logistics

JACKSONVILLE, Fla.–(BUSINESS WIRE)–First Coast Cardiovascular Institute (FCCI) announced today that it is partnering with national cardiology platform, Cardiovascular Logistics (CVL), to enhance and expand its cardiovascular care and services throughout Northern Florida & Southern Georgia. CVL is the most comprehensive cardiovascular platform in the country. By partnering with CVL, FCCI […]

CWRU and UH researchers secure $6.2 million from NIH to investigate using artificial intelligence to predict cardiovascular disease

Researchers from Case Western Reserve University and University Hospitals Cleveland Medical Center (UH) have secured $6.2 million from two grants awarded in the same month from the National Institutes of Health (NIH) to predict cardiovascular disease through new artificial intelligence (AI) approaches. The study will employ cutting-edge AI techniques using machine- and deep-learning models to recognize […]

Semler Scientific Announces Appointment of Eric Semler and William Chang as Directors

Eric Semler Appointed as Chairman SANTA CLARA, Calif., April 19, 2023 /PRNewswire/ — – Semler Scientific, Inc. (Nasdaq: SMLR) today announced that Eric Semler and William H.C. Chang (together, the “Investors”), who collectively beneficially own more than 20% of Semler Scientific’s outstanding shares, will immediately join Semler Scientific’s board of directors as new independent directors. Mr. Semler […]

Cercare Medical brings their Neurovascular Clinical Workflows into ConcertAI’s TeraRecon Eureka Clinical AI Platform in new Partnership

New partnership incorporates latest perfusion technology into neurological CT and MR imaging CAMBRIDGE, Mass., April 20, 2023 /PRNewswire/ — The Eureka Clinical AI platform from ConcertAI’s TeraRecon provides clinicians with the state-of-the-artand deep learning technologies to deliver next-level CT and MR imaging through Cercare Perfusion, a fully-automated, simple-to-use, patient-specific perfusion software. Brain […]

University of Technology Sydney researchers develop ground-breaking heart failure treatment using 3D-printed heart tissue

New technology enables ‘patches’ of 3D printed tissue to be applied onto the surface of damaged hearts as a safer and more cost-effective alternative to heart transplants. SYDNEY, April 20, 2023 /PRNewswire/ — Researchers from The University of Technology Sydney (UTS) have demonstrated that 3D bioprinted heart tissues can safely and effectively […]

Acutus Medical Announces Preliminary Unaudited First Quarter 2023 Results

CARLSBAD, Calif., April 20, 2023 (GLOBE NEWSWIRE) — Acutus Medical, Inc. (“Acutus” or the “Company”) (Nasdaq: AFIB), an arrhythmia management company focused on improving the way cardiac arrhythmias are diagnosed and treated, today announced preliminary unaudited results for the first quarter 2023 in addition to the release of the RECOVER […]

RECOVER AF Study Reports 91% of First Redo Patients Achieved Freedom from AF at One Year After AcQMap-guided Ablation Therapy

CARLSBAD, Calif., April 20, 2023 (GLOBE NEWSWIRE) — Acutus Medical, Inc. (“Acutus”) (Nasdaq: AFIB), an arrhythmia management company focused on improving the way cardiac arrhythmias are diagnosed and treated, today announced results from the RECOVER AF study. The study, published online in EP Europace, found that patients who received AcQMap-guided ablations […]